A Multicenter, Non-Randomized, Open Label Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults
A Multicenter, Non-Randomized, Open Label Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults
To evaluate the clinical efficacy and safety in patients with mild or moderate community-acquired pneumonia receiving a dose of 2 g of azithromycin in the SR formulation.
Inclusion Criteria:
Exclusion Criteria:
Kasuya-gun, Fukuoka 811-2122, Japan
Kamikawa-gun, Hokkaido 071-1521, Japan
Teine, Hokkaido 006-0032, Japan
Oita City, Oita, Oita Prefecture 870-0161, Japan
Nakagami-gun, Okinawa 903-0215, Japan
Shimajiri-gun, Okinawa 901-1303, Japan
Kita-ku, Osaka 530-0004, Japan
Shinagawa, Tokyo 140-0011, Japan